 |
 |
|
|
RESÚMENES MAYO 2005 |
Psychotic Disorders & Antipsychotics
(Requiere estar conectado a internet. Haga un click en la
información del journal)
Carol Paton, Raadiyya Esop
Psychiatric Bulletin (2005) 29: 186-188
Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder. Computational morphometry study
Colm McDonald, Ed Bullmore, MRCPsych, Pak Sham, Xavier Chitnis, John
Suckling, James MacCabe, Muriel Walshe, and Robin M. Murray
The British Journal of Psychiatry (2005) 186: 369-377
D.G. Cunningham Owens, Patrick Miller, Stephen M. Lawrie, and Eve C.
Johnstone
The British Journal of Psychiatry (2005) 186: 386-393
Maxine X. Patel and Anthony S. David
Advances in Psychiatric
Treatment (2005) 11: 203-211
Nina Schooler, Jonathan Rabinowitz, Michael Davidson, Robin Emsley,
Philip D. Harvey, Lili Kopala, Patrick D. McGorry, Ilse Van Hove, Marielle
Eerdekens, Wim Swyzen, and Goedele De Smedt
Am J Psychiatry 162:947-953,
May 2005
Shitij Kapur, Tamara Arenovich, Ofer Agid, Robert Zipursky, Stacy
Lindborg, and Barry Jones
Am J Psychiatry 162:939-946,
May 2005
A Double-Blind, Placebo-Controlled Trial of Sibutramine for Olanzapine-Associated Weight Gain
David C. Henderson, Paul M. Copeland, Tara B. Daley, Christina P.
Borba, Corrine Cather, Dana D. Nguyen, Pearl M. Louie, A. Eden Evins, Oliver
Freudenreich, Doug Hayden, and Donald C. Goff
Am J Psychiatry 162:954-962,
May 2005
Susan R. McGurk, Cameron Carter, Robert Goldman, Michael F. Green,
Stephen R. Marder, Haiyi Xie, Nina R. Schooler, and John M. Kane
Am J Psychiatry 162:1013-1016, May 2005
Violence,
misconduct and schizophrenia: Outcome after four years of optimal treatment
Marina
Economou, Alexandra Palli and Ian RH Falloon
Clinical
Practice and Epidemiology in Mental Health 2005, 1:3; 28 April 2005
Plasma
Concentrations of Risperidone and Olanzapine during Coadministration with
Oxcarbazepine
Rosaria Muscatello M, Pacetti M, Cacciola M, La Torre D, Zoccali R, Arrigo CD,
Migliardi G, Spina E
Epilepsia. 2005 May;46(5):771-4
D. Naber, A. Karow, M. Lambert
Acta Psychiatrica Scandinavica. Volume 111 Issue
s427 Page 29 - June 2005
A. G. Awad, L. N. P. Voruganti
Acta Psychiatrica Scandinavica. Volume 111 Issue
s427 Page 6 - June 2005
S. R. Marder
Acta Psychiatrica Scandinavica. Volume 111 Issue
s427 Page 43 - June 2005
QTc Variability in Schizophrenia Patients Treated With Antipsychotics
and Healthy Controls
Rettenbacher, Maria A.; Eder-Ischia,
Ursula; Bader, Angelika; Edlinger, Monika; Hofer, Alex; Hummer, Martina;
Kemmler, Georg; Weiss, Elisabeth M.; Hochleitner, Monika; Fleischhacker, W.
Wolfgang
Journal of Clinical Psychopharmacology. 25(3):206-210,
June 2005
Influence of Topiramate on Olanzapine-Related Adiposity in Women: A
Random, Double-Blind, Placebo-Controlled Study
Nickel, Marius K.; Nickel, Cerstin;
Muehlbacher, Moritz; Leiberich, Peter K.; Kaplan, Patrick; Lahmann, Claas;
Tritt, Karin; Krawczyk, Jakub; Kettler, Christian; Egger, Christoph; Rother,
Wolfhardt K.; Loew, Thomas H
Journal of Clinical Psychopharmacology. 25(3):211-217,
June 2005
The Effect of Citalopram Adjunctive Treatment Added to Atypical
Antipsychotic Medications for Cognitive Performance in Patients With
Schizophrenia
Friedman, Joseph I.; Ocampo, Ramoncito; Elbaz, Zeinab;
Parrella, Michael; White, Leonard; Bowler, Stephanie; Davis, Kenneth L.;
Harvey, Philip D
Journal of Clinical Psychopharmacology. 25(3):237-242,
June 2005
The Association of Weight Gain and Olanzapine Plasma Concentrations
Perry, Paul J.; Argo, Tami R.; Carnahan,
Ryan M.; Lund, Brian C.; Holman, Timothy L.; Ellingrod, Vicki L.; Miller, Del
Journal of Clinical Psychopharmacology. 25(3):250-254,
June 2005
Association
Between Early and Rapid Weight Gain and Change in Weight Over One Year of
Olanzapine Therapy in Patients with Schizophrenia and Related Disorders
Kinon, Bruce J.; Kaiser, Christopher J.; Ahmed, Saeed;
Rotelli, Matthew D.; Kollack-Walker, Sara
Journal of Clinical Psychopharmacology. 25(3):255-258,
June 2005
Bone Mineral Density and Its Relationship to Prolactin Levels in
Patients Taking Antipsychotic Treatment
Howes, Oliver D.; Wheeler, Michael J.;
Meaney, Anna-Maria; O'Keane, Veronica; Fogelman, Ignac; Blake, Glen; Murray,
Robin M.; Smith, Shubulade
Journal of Clinical Psychopharmacology. 25(3):259-261,
June 2005
Pharmacogenetic studies of response to risperidone and other newer
atypical antipsychotics
Hsien-Yuan Lane, Cheng-Chun Lee, Yi-Ching Liu & Wen-Ho Chang
Pharmacogenomics. March 2005, Vol. 6, No. 2, Pages 139-149
Influence of Aging on the Improvement of Subjective Sleep Quality by Atypical Antipsychotic Drugs in Patients With Schizophrenia. Comparison of Middle-Aged and Older Adults
Hidehisa Yamashita, Kazuhiko Mori, Masatsugu Nagao, Yasumasa Okamoto,
Shigeru Morinobu, and Shigeto Yamawaki
Am J Geriatr Psychiatry 13:377-384, May 2005
Doron Mazeh, Channa Zemishlani, Dov Aizenberg, and Yoram Barak
Am J Geriatr Psychiatry 13:417-419, May 2005
Chronic
treatment with haloperidol induces deficits in working memory and feedback
effects of interval timing
Cindy Lustig and
Warren H. Meck
Brain and Cognition. Volume 58, Issue 1, June 2005,
Pages 9-16
Trevor B. Penney,
Warren H. Meck, Simone A. Roberts, John Gibbon and L. Erlenmeyer-Kimling
Brain and Cognition. Volume 58, Issue 1, June 2005, Pages
109-118
Armanda C.T.B.F.
Rufino, Ricardo R. Uchida, José A.A. Vilela, João M.A. Marques, Antonio W.
Zuardi and Cristina M. Del-Ben
General Hospital Psychiatry. Volume 27, Issue 3,
May-June 2005, Pages 189-193
Hippocampus and
amygdala volumes in schizophrenia and other psychoses in the Northern Finland
1966 birth cohort
Päivikki Tanskanen,
Juha M. Veijola, Ulla K. Piippo, Marianne Haapea, Jouko A. Miettunen, Juhani
Pyhtinen, Edward T. Bullmore, Peter B. Jones and Matti K. Isohanni
Schizophrenia
Research. Volume 75, Issues 2-3, 15 June 2005, Pages 283-294
Hippocampal and
anterior cingulate morphology in subjects at ultra-high-risk for psychosis: the
role of family history of psychotic illness
Stephen J. Wood,
Murat Yücel, Dennis Velakoulis, Lisa J. Phillips, Alison R. Yung, Warrick Brewer,
Patrick D. McGorry and Christos Pantelis
Schizophrenia
Research. Volume 75, Issues 2-3, 15 June 2005, Pages 295-301
Roger J. Jou,
Antonio Y. Hardan and Matcheri S. Keshavan
Schizophrenia
Research. Volume 75, Issues 2-3, 15 June 2005, Pages 309-313
M.K. Harte, S.B.
Bachus and G.P. Reynolds
Schizophrenia
Research. Volume 75, Issues 2-3, 15 June 2005, Pages 303-308
Three-year recovery
outcomes for long-term patients with co-occurring schizophrenic and substance
use disorders
Haiyi Xie, Gregory
J. McHugo, Barbara S. Helmstetter and Robert E. Drake
Schizophrenia
Research. Volume 75, Issues 2-3, 15 June 2005, Pages 337-348
Obsessive–compulsive
symptoms in schizophrenia: associated clinical features, cognitive function and
medication status
Dost Öngür and
Donald C. Goff
Schizophrenia
Research. Volume 75, Issues 2-3, 15 June 2005, Pages 349-362
Dermatoglyphics
and Schizophrenia: A meta-analysis and investigation of the impact of obstetric
complications upon a–b ridge count
Elvira Bramon,
Muriel Walshe, Colm McDonald, Beatriz Martín, Timothea Toulopoulou, Harvey
Wickham, Jim van Os, Paul Fearon, Pak C. Sham, Lourdes Fañanás and Robin M.
Murray
Schizophrenia
Research. Volume 75, Issues 2-3, 15 June 2005, Pages 399-404
Tanja Svirskis,
Jyrki Korkeila, Markus Heinimaa, Jukka Huttunen, Tuula Ilonen, Terja Ristkari,
Thomas McGlashan and Raimo K.R. Salokangas
Schizophrenia
Research. Volume 75, Issues 2-3, 15 June 2005, Pages 439-446
A 4-Fold Risk of Metabolic Syndrome in Patients With
Schizophrenia: The Northern Finland 1966 Birth Cohort Study
Kaisa M. Saari,
Sari M. Lindeman, Kaisa M. Viilo, Matti K. Isohanni, Marjo-Riitta Järvelin,
Liisa H. Laurén, Markku J. Savolainen, and Hannu J. Koponen
J Clin Psychiatry 2005;66:559-563
Dag Aarsland,
Robert Perry, Jan P. Larsen, Ian G. McKeith, John T. O'Brien, Elaine K. Perry,
David Burn, and Clive G. Ballard
J Clin Psychiatry 2005;66:633-637
Long-Term Maintenance Therapy With Quetiapine Versus
Haloperidol Decanoate in Patients With Schizophrenia or Schizoaffective
Disorder
Ira D. Glick, and
Stephen R. Marder
J Clin Psychiatry 2005;66:638-641
Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness
William G. Honer, Lili C. Kopala, Jonathan Rabinowit
Journal of
Psychopharmacology, Vol. 19, No. 3, 277-285 (2005)
Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?
A. Kalyoncu, H. Mirsal, Ö. Pekta, N. Ünsalan, D. Tan, M. Beyazyürek
Journal
of Psychopharmacology, Vol. 19, No. 3, 301-305 (2005)
A
retrospective chart review of the clinical effects of atypical antipsychotic
drugs on glycemic control in institutionalized patients with schizophrenia and
comorbid Mellitus
Diabetes
Krosnick A, Wilson
MG
Clin Ther. 2005
Mar;27(3):320-6
The
dosing of atypical antipsychotics
de Leon J, Armstrong SC, Cozza KL
Psychosomatics. 2005 May-Jun;46(3):262-73
BULENT KAYAHAN,
OZGUR OZTURK, BAYBARS VEZNEDAROGLU, AND DEFNE ERASLAN
Psychiatry and Clinical Neurosciences. Volume
59 Issue 3 Page 291 - June 2005
Gait
disturbances in patients with schizophrenia and adaptation to treadmill
walking.
Putzhammer A, Perfahl M,
Pfeiff L, Hajak G
Psychiatry Clin Neurosci. 2005 Jun;59(3):303-310
Clozapine:
a new explanation for its atypical character.
Sokoloff P
Int J Neuropsychopharmacol. 2005 May 13;:1-3 [Epub
ahead of print]
Right
hemisphere language functions and schizophrenia: the forgotten hemisphere?
Mitchell RL, Crow TJ
Brain. 2005 May;128(Pt 5):963-78
Pharmacokinetics,
Safety, and Tolerability of Intramuscular Ziprasidone in Healthy Volunteers
Miceli JJ, Wilner KD, Swan
SK Md, Tensfeldt TG
J Clin Pharmacol. 2005 Jun;45(6):620-630
Antipsychotic
monotherapy and polypharmacy in the naturalistic treatment of schizophrenia
with atypical antipsychotics
Douglas
E Faries, Haya Ascher-Svanum, Baojin Zhu, Christoph U Correll and John Kane
BMC Psychiatry 2005, 5:26; 27 May 2005
Pharmacological
management of acute agitation.
Battaglia J.
Daniel Umbricht and
Sanya Krljes
Schizophrenia
Research. Volume 76, Issue 1, 1 July 2005, Pages 1-23
Dongsoo Kim, Vance
Zemon, Alice Saperstein, Pamela D. Butler and Daniel C. Javitt
Schizophrenia
Research. Volume 76, Issue 1, 1 July 2005, Pages 55-65
Manuel Gurpegui,
José M. Martínez-Ortega, M. Carmen Aguilar, Francisco J. Diaz, Hernando M.
Quintana and Jose de Leon
Schizophrenia
Research. Volume 76, Issue 1, 1 July 2005, Pages 113-118
Pharmacopsychiatry. 2005 May;38(3):113-7
A screening
study of antidepressant treatment rates and mood symptoms in pregnancy
S. M. Marcus,
H. A. Flynn, F. Blow and K. Barry
Archives
of Women's Mental Health 2005; Volume 8, Number 1: 25 - 27
Exposure
measures applied to the bioequivalence of two sustained release formulations of
bupropion
Midha KK, Rawson MJ, McKay G, Hubbard JW
Int J Clin Pharmacol Ther. 2005 May;43(5):244-54
Lachlan A.
McWilliams, Brian J. Cox and Gordon J.G. Asmundson
Journal
of Anxiety Disorders. Volume 19, Issue 6, 2005, Pages 626-641
Gail A. Bernstein,
Ann E. Layne, Elizabeth A. Egan and Lara P. Nelson
Journal
of Anxiety Disorders. Volume 19, Issue 6, 2005, Pages 658-672